Biopharma & Biotech Analyst Kim and Biotech Analyst Kluska, along with Dr. Ehsan Rahimy, Surgical & Medical Retinal Specialist at Stanford University, discuss current trends, unmet needs and upcoming treatments in retinal diseases on an Analyst/Industry conference call to be held on August 2 at 1:30 pm. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on EYPT:
- EyePoint Pharmaceuticals Reports Second Quarter 2023 Financial Results and Highlights Recent Corporate Developments
- EyePoint reports Q2 EPS (61c), consensus 60c
- Cantor biotech/biopharma analysts to hold analyst/industry conference call
- EyePoint presents interim masked safety data for DAVIO 2 trial
- EyePoint Pharmaceuticals to Report Second Quarter 2023 Financial Results on August 2, 2023